Hansa Biopharma — Maj 2024
-
Godmorgen
hvad stiger den på ? ikke fordi short% er faldet meget nu 4,88% og ingen insiderkøb ( de kunne kigge på chemoMetec ledelsen og tage ved lære :-)) ingen nyheder så hvad stiger den på ?altså ud over den er total sønderbombet 87% nede siden toppen for 4 år siden -
@LP90 - prøv at holde øje med de små drypvise gode nyheder som hist og pist dukker op fx:
https://karger.com/tmh/article/doi/10.1159/000538513/906326/Successful-Desensitization-with-Imlifidase-and (Successful Desensitization with Imlifidase and Daratumumab)
... måske er det summen af gode data som langsomt smitter af på kursudviklingen.
-
Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
-
Hansa Biopharma AB: Hansa Biopharma slutför randomisering i den pivotala fas 3-studien ConfIdeS i USA
i dag kl. 13:30 ∙ CisionL
-
Hansa Biopharma slutför randomisering i den pivotala fas 3-studien ConfIdeS i USA
Lund, Sverige, 31 maj 2024. Hansa Biopharma AB, (”Hansa” eller ”bolaget”) (Nasdaq Stockholm: HNSA)
News Powered by Cision (news.cision.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind